Pediatrix Medical Group (PDC) Stock Price & Analysis
PDC Stock Chart & Stats
- Day’s Range
- EUR 25.80 - EUR 26.20
- 52-Week Range
- EUR 14.60 - EUR 26.20
- Previous Close
- EUR 25.60
- Volume
- N/A
- Average Volume (3M)
- 8
- Market Cap
- EUR 2.08B
- Enterprise Value
- EUR 2.24B
- Total Cash (Recent Filing)
- EUR 425.84M
- Total Debt (Recent Filing)
- EUR 612.00M
- Price to Earnings (P/E)
- 16.4
- Beta
- 0.11
- Next Earnings
- Feb 18, 2027 (Est.)
- EPS Estimate
- 0.57
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Profitability And Revenue Growth
The shift from recent net losses to solid profitability, alongside accelerating revenue, indicates meaningful improvement in operating performance. If maintained, stronger earnings can support investment in clinical capacity, technology, acquisitions, and other initiatives that reinforce Pediatrix’s position in women’s and children’s healthcare.
Strong Cash Generation
Healthy free cash flow that broadly tracks reported earnings gives Pediatrix internally generated funding for debt reduction, acquisitions, technology investment, and shareholder returns. This cash generation provides resilience and strategic flexibility across the next several quarters, even though recent growth moderated.
Improving Leverage And Acquisition Capacity
Lower leverage and substantial cash improve financial flexibility relative to prior years. Management’s stated ability to consider larger acquisitions in adjacent women’s and children’s health businesses could broaden the service platform, add scale, and create additional avenues for durable growth.
Bears Say
Cost And Margin Pressure
Revenue growth has not translated proportionally into gross profit or EBITDA growth, indicating pressure from cost structure or business mix. Continued increases in clinical labor, practice expenses, and corporate costs could limit margin expansion and reduce the earnings benefit of future top-line growth.
Moderating Cash Conversion
Although absolute cash generation remains strong, declining free cash flow and lower quarterly operating cash flow suggest weaker near-term conversion of earnings into cash. If this persists, Pediatrix may have less internally funded capacity for acquisitions, investment, debt repayment, or shareholder distributions.
Hospital And Service-line Uncertainty
Pediatrix depends on hospital relationships and physician-service volumes, so pressure in the hospital environment can affect administrative fees and service economics. Declines in some neonatology areas and unresolved OB coding changes add uncertainty to volume and reimbursement durability.
Pediatrix Medical Group News
PDC FAQ
What was Pediatrix Medical Group’s price range in the past 12 months?
What is Pediatrix Medical Group’s market cap?
When is Pediatrix Medical Group’s upcoming earnings report date?
How were Pediatrix Medical Group’s earnings last quarter?
Is Pediatrix Medical Group overvalued?
Does Pediatrix Medical Group pay dividends?
What is Pediatrix Medical Group’s EPS estimate?
How many shares outstanding does Pediatrix Medical Group have?
What happened to Pediatrix Medical Group’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Pediatrix Medical Group?
What is the TipRanks Smart Score and how is it calculated?
Pediatrix Medical Group Stock Smart Score
Company Description
Pediatrix Medical Group
Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix provides comprehensive maternal-fetal medicine services in both clinical and inpatient settings, involving specialists such as maternal-fetal medicine physicians, obstetricians, and genetic counselors. Furthermore, the group delivers pediatric cardiology services, addressing both congenital and acquired heart conditions in patients ranging from the fetal stage through adulthood, under the care of dedicated pediatric cardiologists. Beyond these core areas, Pediatrix extends its expertise to various other pediatric subspecialties, including those requiring intensivists, surgeons, and ophthalmologists, and supplies vital support to hospital departments like emergency rooms and labor and delivery units. Established in 1979 in Sunrise, Florida, and formerly known as MEDNAX, Inc. until its renaming in July 2022, the company managed a network of approximately 2,700 physicians as of February 2022.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Mark S. Ordan
- Employees
- 4,280
- Website
- www.pediatrix.com
- Address
- 1301 Concord Terrace, Sunrise, FL, 33323, US
Pediatrix Medical Group (PDC) Earnings & Revenues
PDC Earnings Call
Earnings Call SentimentPositive
The call was predominantly positive: Pediatrix reported adjusted EBITDA above expectations, revenue and same-unit growth, favorable payer mix and pricing drivers, substantial share repurchases, low leverage, and continued strategic flexibility. Offsetting concerns included lower operating cash flow, higher labor and other operating costs, the reversal of prior collection-related pricing benefits, declines in certain neonatology services, and regulatory and hospital-environment uncertainty.
View all DE:PDC earnings summariesPDC Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 1 | 6 |
| Technical Analysis | 3 | 1 | 6 |
| Moving Averages | 12 | 0 | 0 |
